Close Menu

Danaher

News items for in vitro diagnostics industry for the week of Sept. 14, 2020.

While the market ditched shares of many other diagnostics firms, analysts said the reaction was overblown, particularly in the case of Quidel and molecular diagnostics players.

The companies are validating the Genedrive 96 Sars-CoV-2 kit using saliva samples extracted with Beckman Coulter's RNAdvance viral extraction chemistry

For the three months ended July 3, the Washington DC-based conglomerate recorded $5.30 billion in total sales compared to $4.44 billion in the year-ago period.

The firm launched a CE-IVD marked test for extremely drug-resistant TB and expects to incorporate the multiplexing technology in other assays.

The firm said it intends to use the credit facility to support its US and European commercial paper programs and for general corporate purposes.

Bio-Techne said pathologists now have access to its fully automated RNAscope technology, providing them with a new tool to evaluate disease biomarkers.

The award amount is about $2.3 million, BARDA said, while a Beckman Coulter spokesperson added the full contract is valued at up to $8.06 million.

News items for in vitro diagnostics industry for the week of May 11, 2020.

Only 2.5 percent of Americans have been tested for COVID-19, even as industry scrambles to increase testing capacity and a second wave of cases may hit in the fall.

Pages